Mitigating Age-Related Memory Loss with a New Brain-penetrant Lipid Therapy
Official title: Mitigating Age-Related Cognitive Decline through a First-in-Class Lipid Neurogenic Therapy
Funded at Immunova, LLC · NIH-11395066 · Data updated 2026-11-12
A small, early-stage project tests a new brain-penetrant lipid therapy intended to boost brain regeneration and reduce age-related memory decline in conditions like Alzheimer’s disease and ADRD.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Immunova, LLC NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | September 17, 2026 |
| Project end | September 16, 2027 |
| Funding year | 2026 |
| Award (this year) | $459,616 |
| NIH project number | 1R43AG102094-01 |
| Project ID | NIH-11395066 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with age-related cognitive concerns or early-stage AD/ADRD who could participate in future trials once safety and efficacy are established.
✕Less likely to help
Individuals without age-related cognitive decline or dementia may not benefit from this early-stage therapy.
What this research studies
This grant supports a first-in-class approach to help aging brains by using LEA compounds that act on neural stem cell regulators TLX and the GPR6 receptor. The work will synthesize lead compounds, confirm their binding and activity, test their ability to restore aging brain cells in lab models, and evaluate brain penetration and safety in mice. It focuses on building a proof-of-concept for a therapy that could slow or reverse aspects of cognitive aging by promoting neurogenesis. If successful, the project could pave the way for future clinical development targeting age-related memory impairment and related dementias.
Why it matters
Potential benefit: If successful, this therapy could slow or reverse certain aspects of age-related cognitive decline by promoting brain repair.
How similar studies have gone: Previous similar approaches have shown promise in preclinical models, but this is a novel first-in-class strategy with multiple targets.
Where this research is happening
-
Immunova, LLC
Gainesville, United States Active
Researchers
- Principal investigator: Svetlov, Stanislav I — Immunova, LLC
- Study coordinator: Svetlov, Stanislav I
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
NGF Metabolism as a biomarker for cognitive decline in familial Alzheimer's disease
Researchers are studying whether patterns in nerve growth factor pathways in blood and CSF can signal early, preclinical stages of Alzheimer's in people with genetic risk.
-
NGF metabolism as an early biomarker for cognitive decline in familial Alzheimer's disease
This project tests whether NGF pathway proteins in blood and CSF can signal early, preclinical changes in people with familial Alzheimer’s disease.
-
NGF Metabolic Dysfunction as a Marker of Cognitive Decline in Autosomal Dominant Alzheimer's Disease
This project looks at nerve growth factor pathways in people with a genetic form of Alzheimer's to see if blood and spinal fluid markers can identify early brain changes before symptoms appear.
-
Optimizing a closed-loop digital meditation to help cognitive aging and stress in older adults
A mobile, personalized meditation program is being tested to help older adults maintain thinking skills and lower stress.
-
Cash transfers in South Africa to reduce dementia risk in later life
This project tests whether government cash transfers in rural South Africa help protect people’s thinking and memory as they age.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.